Regulatory
Saudi Food and Drug Authority(SFDA)
In one line
Saudi Arabian medical device regulator; central authority for the GCC reliance pathway.
Definition
SFDA enforces the Medical Device Interim Regulation, requires Medical Device Marketing Authorisation (MDMA), and operates GHAD for device registration. It often relies on existing FDA, EU, Health Canada, TGA, or PMDA approvals for streamlined review.
Saudi Arabia's Food and Drug Authority requires a Medical Device Marketing Authorization (MDMA) before devices are supplied, typically supported by approval in a reference jurisdiction such as the US, EU, Australia, Canada or Japan. Foreign manufacturers need an Authorized Representative in Saudi Arabia, devices must be listed in the national registry, and post-market obligations include incident reporting and field safety corrective actions.
Why it matters
Increasingly important for global launch sequencing in the Middle East; reliance pathways meaningfully shorten timelines.
Common pitfalls
- •A common pitfall is underestimating the specific documentation requirements for SFDA despite reliance pathways, as local representation and specific declarations are still needed.
- •Another mistake is assuming full reciprocity with other major regulators without understanding the SFDA's unique submission format and portal requirements.
- •Failing to maintain updated device registrations and marketing authorizations in GHAD can lead to compliance issues and market access disruptions.
- •Companies sometimes overlook the importance of local authorized representation, which is a mandatory requirement for medical device registration and vigilance in Saudi Arabia.
Sources
- FDA - Medical Devices · FDA
- European Commission - Medical Devices · European Commission
- IMDRF Documents · IMDRF